A Novel Mutation in the FcγRIIIA Gene (CD16) Results in Active Natural Killer Cells Lacking CD16

References

• Robertson. M.J. and Ritz. J. Biology and clinical relevance of human natural killer cells. Blood 1990: 76: 2421 38.
   Google Scholar
• Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 1989; 47: 187 376."
   Google Scholar
• Biron. C.A., Byron. K.S. and Sullivan. J.L. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989: 320: 1731 5.
   Google Scholar
• Bailas. Z.K. Turner, J.M. Turner. D.A. Goetzman. E.A. and Kemp. J.D. A patient with simultaneous absence of "classical" natural killer cells (CD3 . CD16-, and NKH1+) and expansion of CD3 ) . CD4 . CD8 . NK.H 1+ subsetJ. Allergy Clin. Immunol. 1990: 85: 453 9.
   Google Scholar
• Lanier. L.L., Testi. R. Bindl. J. and Phillips, J.H. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural adhesion moleculeJ. Exp. Med. 1989; 169: 2233
   Google Scholar
• Lanier. L.L., Chang, C. Azuma. M. Ruitcnberg. J.J. Hempcrly. J.J. and Phillips. J.H. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J. Immunol. 1991: 146: 4421
   Google Scholar
• Gherman. M. Manciulea. M. Bancu, A.C. Sulica, A. Stanworth, D.R. and Herberman, R.B. Regulation of human natural cytotoxity by lgG. 1. Characterization of the structural site on monomeric lgG responsible for inhibiting natural killer cell activity. Mol. Immunol. 1987: 24: 743–50.
   Google Scholar
• Bonnema. J.D., Karnitz, L.M., Schoon, R.A. Abraham, R.T. and Leibson, P.J. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-indcpendent granule release and cell-mediated cytotoxicity. J. Exp. Med. 1994: 180: 1427–35.
   PubMedGoogle Scholar
• Selvaraj, P. Carpen. O. Hibbs. M.L. and Springer. T.A. Natural killer cell and granulocyte Fc-/ receptor 111 (CD 16) differ in membrane anchor and signal transduction. J. Immunol. 1989; 143: 3283–8.
   Google Scholar
• Van de Winkel. J.G.J, and Anderson. C.L. Biology of human immunoglobulin G Fc receptors. J. Leukoe. Biol. 1991:49: 511–24.
   Google Scholar
• Ravetch, J.V. and Perussia, B. Alternative membrane forms of Fc/RIll (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 1989; 170: 481–97.
   Google Scholar
• Sclvaraj, P. Rosse. W.F. Silbcr. R. and Springer. T.A. The major Fc receptor in blood has a phosphalidylinositol anchor and is deficient in paroxysmal nocturnal haemoglo-binuria. Nature 1988; 333: 565–7.
   Google Scholar
• de Haas. M. Koene. H.R. Klcijer, M., de Vries. E. Simsck. S. van Toi. M.J.D. et al. A triallclic Fc7 receptor type III A polymorphism influences the binding of human IgG by NK cell Fc7RIllAJ. Immunol. 1996; 156: 2948–55.
   Google Scholar
• Jawahar. S. Moody. C. Chan. M. Finberg. R. Geha. R. and Chalila. T. Natural killer (NK) cell deficiency associated with an cpitope-dcficicnt Fc receptor type 111A (CD16-II). Clin. Exp. Immunol. 1996: 103: 408–13.
   Google Scholar
• de Vries. E., Koene, H.R., Vossen,J.M.,Gratama.J.W., von dem Borne. A.E.G.K., Waaijcr. J.L.M. et al. Identification of an unusual Fc-/ receptor Illa (CD16) on natural killer cells in a patient with recurrent infections. Blood 1996: 88: 3022–7.
   Google Scholar
• Wu.J.Edberg.J.C.,Redecha.P.B.,Bansal.V.Guyre.P.M. Coleman. K. et al. A novel polymorphism of Fc7RIIla (CD 16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 1997; 100: 1059 70.
   Google Scholar
• Wigzcll, H. and Ramstedt. U. Natural killer cells. In: D. Weir. L.A. Herzenbcrg, C. Blackwell and L.A. Herzenbcrg (Ed.). Handbook of Experimental Immunology. Vol. 2 Oxford: Blackwell. 1986. pp. 60
   Google Scholar
• Hanaumi. K. Hinuma. S. and Kumagai. K. ADCC. In: S. Migita, S. Konda. T. Honjo and T. Hamaoka (Ed.), Experimental Manual of Immunology. Tokyo: Nankodo Co. 1995. pp. 718–23.
   Google Scholar
• Farrcl Jr. R.E. Protocol: Guunidinium CsCl isopyenic purification of RNA. In: RNA Methodologies. San Diego: Academic Press, 1993, pp. 58–62.
   Google Scholar
• Koene, H.R. Klcijer. M. Algra. H., Roos. D., von dem Borne, A.E.G.K. and dc Haas. Masja. Fc7RIIIa-158V/F polymorphism influence the binding of IgG by natural killcrcell FC7RIII11. independently of the Fc7RIIIa-48L R H phenotype. Blood 1997: 90: 1109–14.
   Google Scholar
• Gcssner. J.E. Grusscnmeyer. T. Kolanur, W. and Schmidt. R.E. The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J. Biol. Client. 1995: 270: 1350–61.
   Google Scholar
• Nagler. A. Lanier. L.L. Cwirla. S. and Phillips. J.H. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989: 143: 3183
   Google Scholar
• Metes. D. Ernst. L.K. Chambers. W.H. Sulica. A. Herbcrman. R.B. and Morel. P.A. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FC7RIIC gene. Blood 1998:91: 2369–80.
   Google Scholar
• Mantozioris. B.X. Berger. M.F. Sewell. W. and Zola. H. Expression of the Fc receptor for IgG (FC7RII CD32\\) by human circulating T and B lymphocytesJ. Immunol. 1993: 150: 5175–84.
   Google Scholar
• Ravetch. J.V. Fc receptors: Rubor redox. Cell 1994; 78: 553 60.
   Google Scholar
• Van dc Winkel. J.G.J, and Capel. P.J.A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 1993; 14: 215–21.
   Google Scholar
• Ada. G. Twenty years into the saga of MHC-rcstriction. Immunol. Cell Biol. 1994: 72: 447 54.
   Google Scholar
• Van dcr Pol. W.L. and van de Winkel. J.G.J. IgG receptor polymorphisms: risk factors for disease. Iminunogenet. 1998:48: 222 32.
   Google Scholar
• Wu.J.,Edberg.J.C.Redecha.P.B.Bansal.V.Guyre.P.M. Coleman, K. Salmon. J.E. and Kimberly. R. A novel polymorphism of Fc7RIIIa (CD 16) alters receptor function and predisposes to autoimmune disease. J. Clin. Inveii. 1997; 100: 1059–70.
   Google Scholar
• Wainstein, E., Edberg, J., Csernok. E., Schellcr. M. Hoffman, G. Keystone. E. Gross, W. Salmon, J. and Kimberly, R. FC7RIIIB alleles predict renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum. 1996; 39: S210.~
   Google Scholar
• Duits. A.J. Bootsma. H. Derkscn. R.H.W.M. Spronk. O.E. Kater. L., Kallenberg. G.G.M. Capel. P.J.A., Westerdaal, N.A.C., Spicrenbury. G.T. Gmelig-Mcyling. F.H.J, and van de Winkel, J.G.J. Skewed distribution of IgG FC7 receptor lia (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995; 39: 1832–6.
   Google Scholar